Optimizing Ribavirin Exposure by Therapeutic Drug Monitoring Improves Treatment Response in Patients With Chronic Hepatitis C Genotype 1

被引：6
作者：
Stickel, Felix [1 ]
Worni, Mathias [1 ]
Pache, Isabelle [2 ]
Moradpour, Darius [2 ]
Helbling, Beat [3 ]
Borovicka, Jan [4 ]
Gerlach, Tilman J. [4 ]
机构：
[1] Univ Bern, Inselspital, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland
[2] Univ Lausanne, Div Gastroenterol & Hepatol, CHUV, Lausanne, Switzerland
[3] Stadtspital Waid, Dept Gastroenterol, Zurich, Switzerland
[4] Kantonsspital, Dept Gastroenterol & Hepatol, St Gallen, Switzerland
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷 / 07期
关键词：
HCV INFECTION; PEGINTERFERON;
D O I：
10.1038/ajg.2013.140
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1176 / 1178
页数：3
相关论文
共 11 条
  • [1] Determination of ribavirin in human serum and plasma by capillary electrophoresis
    Breadmore, MC
    Theurillat, R
    Thormann, W
    [J]. ELECTROPHORESIS, 2004, 25 (10-11) : 1615 - 1622
  • [2] Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
    Conjeevaram, Hari S.
    Fried, Michael W.
    Jeffers, Lennox J.
    Terrault, Norah A.
    Wiley-Lucas, Thelma E.
    Afdhal, Nezam
    Brown, Robert S.
    Belle, Steven H.
    Hoofnagle, Jay H.
    Kleiner, David E.
    Howell, Charles D.
    [J]. GASTROENTEROLOGY, 2006, 131 (02) : 470 - 477
  • [3] Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
    Hezode, Christophe
    Forestier, Nicole
    Dusheiko, Geoffrey
    Ferenci, Peter
    Pol, Stanislas
    Goeser, Tobias
    Bronowicki, Jean-Pierre
    Bourliere, Marc
    Gharakhanian, Shahin
    Bengtsson, Leif
    McNair, Lindsay
    George, Shelley
    Kieffer, Tara
    Kwong, Ann
    Kauffman, Robert S.
    Alam, John
    Pawlotsky, Jean-Michel
    Zeuzem, Stefan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) : 1839 - 1850
  • [4] Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1
    Jin, Runyan
    Cai, Ling
    Tan, Ming
    McHutchison, John G.
    Dowling, Thomas C.
    Howell, Charles D.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (11) : 1675 - 1683
  • [5] Clinical utility of interleukin-28B testing in patients with genotype 1
    Lai, Michelle
    Afdhal, Nezam H.
    [J]. HEPATOLOGY, 2012, 56 (01) : 367 - 372
  • [6] Leroy V, LIVER INT
  • [7] Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C
    Loustaud-Ratti, Veronique
    Alain, Sophie
    Rousseau, Annick
    Hubert, Isabelle Fouchard
    Sauvage, Francois Ludovic
    Marquet, Pierre
    Denis, Francois
    Lunel, Francoise
    Cales, Paul
    Lefebvre, Annie
    Fauchais, Anne-Laure
    Liozon, Eric
    Vidal, Elisabeth
    [J]. HEPATOLOGY, 2008, 47 (05) : 1453 - 1461
  • [8] Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care
    Pearlman, Brian L.
    [J]. LANCET INFECTIOUS DISEASES, 2012, 12 (09) : 717 - 728
  • [9] Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha
    Shiffman, Mitchell L.
    Salvatore, Jennifer
    Hubbard, Sarah
    Price, Angie
    Sterling, Richard K.
    Stravitz, R. Todd
    Luketic, Velituir A.
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2007, 46 (02) : 371 - 379
  • [10] Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C
    Stickel, F.
    Helbling, B.
    Heim, M.
    Geier, A.
    Hirschi, C.
    Terziroli, B.
    Wehr, K.
    De Gottardi, A.
    Negro, F.
    Gerlach, T.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2012, 19 (02) : 77 - 87
12